Aliases for PDE9A Gene
External Ids for PDE9A Gene
Previous GeneCards Identifiers for PDE9A Gene
The protein encoded by this gene catalyzes the hydrolysis of cAMP and cGMP to their corresponding monophosphates. The encoded protein plays a role in signal transduction by regulating the intracellular concentration of these cyclic nucleotides. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
GeneCards Summary for PDE9A Gene
PDE9A (Phosphodiesterase 9A) is a Protein Coding gene. Diseases associated with PDE9A include Heart Disease and B-Lymphoblastic Leukemia/Lymphoma With Iamp21. Among its related pathways are Nitric oxide stimulates guanylate cyclase and Response to elevated platelet cytosolic Ca2+. Gene Ontology (GO) annotations related to this gene include 3',5'-cyclic-nucleotide phosphodiesterase activity and 3',5'-cyclic-GMP phosphodiesterase activity. An important paralog of this gene is PDE6B.
UniProtKB/Swiss-Prot Summary for PDE9A Gene
Specifically hydrolyzes the second messenger cGMP, which is a key regulator of many important physiological processes. Highly specific: compared to other members of the cyclic nucleotide phosphodiesterase family, has the highest affinity and selectivity for cGMP (PubMed:9624146, PubMed:18757755, PubMed:21483814). Specifically regulates natriuretic-peptide-dependent cGMP signaling in heart, acting as a regulator of cardiac hypertrophy in myocytes and muscle. Does not regulate nitric oxide-dependent cGMP in heart (PubMed:25799991). Additional experiments are required to confirm whether its ability to hydrolyze natriuretic-peptide-dependent cGMP is specific to heart or is a general feature of the protein (Probable). In brain, involved in cognitive function, such as learning and long-term memory (By similarity).